Related Articles
Comparison of automated and manual determination of HER2 status in breast cancer for diagnostic use: a comparative methodological study using the Ventana BenchMark automated staining system and manual tests.
Detection of human epidermal growth factor receptor 2 protein and gene in fine needle aspiration cytology specimens and tissue sections from invasive breast cancer: Can cytology specimens take the place of tissue sections?
FISH testing of HER2 immunohistochemistry 1+ invasive breast cancer with unfavorable characteristics
Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer
Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: Gene amplification does not contribute to EGFR expression